Reversible permeabilization. A novel technique for the intracellular introduction of antisense oligodeoxynucleotides into intact smooth muscle.
about
Antisense knockdown of inducible nitric oxide synthase inhibits the relaxant effect of VIP in isolated smooth muscle cells of the mouse gastric fundusCalponin is required for agonist-induced signal transduction--evidence from an antisense approach in ferret smooth muscleThe functional consequence of RhoA knockdown by RNA interference in rat cerebral arteriesCaveolin-1 assembles type 1 inositol 1,4,5-trisphosphate receptors and canonical transient receptor potential 3 channels into a functional signaling complex in arterial smooth muscle cellsVasoconstriction resulting from dynamic membrane trafficking of TRPM4 in vascular smooth muscle cellsInhibition of RhoA translocation and calcium sensitization by in vivo ADP-ribosylation with the chimeric toxin DC3BSerine-threonine kinase with-no-lysine 4 (WNK4) controls blood pressure via transient receptor potential canonical 3 (TRPC3) in the vasculatureCa(v)1.2 splice variant with exon 9* is critical for regulation of cerebral artery diameter.Ca(V)1.2 channel N-terminal splice variants modulate functional surface expression in resistance size artery smooth muscle cellsTMEM16A channels generate Ca²⁺-activated Cl⁻ currents in cerebral artery smooth muscle cells.Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase IαRole of dual-specificity protein phosphatase-5 in modulating the myogenic response in rat cerebral arteries.IP3 constricts cerebral arteries via IP3 receptor-mediated TRPC3 channel activation and independently of sarcoplasmic reticulum Ca2+ releaseApoptotic agents inducing genotoxicity-specific chromatin changes.Gi-Protein alpha-subunit mRNA antisense oligonucleotide inhibition of Gi-coupled receptor contractile activity in the epididymis of the guinea-pig.Postsynaptic density-95 scaffolding of Shaker-type K⁺ channels in smooth muscle cells regulates the diameter of cerebral arteries.Isoform-selective physical coupling of TRPC3 channels to IP3 receptors in smooth muscle cells regulates arterial contractility.Protein kinase C regulates vascular myogenic tone through activation of TRPM4.TMEM16A/ANO1 channels contribute to the myogenic response in cerebral arteries.Long-term effects of intracellular calcium and growth factors on excitation and contraction in smooth muscle.Smooth muscle cell alpha2delta-1 subunits are essential for vasoregulation by CaV1.2 channels.Identification and functional implication of a Rho kinase-dependent moesin-EBP50 interaction in noradrenaline-stimulated artery.Chronic treatment with interleukin-1beta attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle.CPI-17 silencing-reduced responsiveness in control and TNF-alpha-treated human bronchi.Cellular effects of antisense c-myc oligodeoxynucleotides are delivery dependent.BK β1 subunit-dependent facilitation of ethanol inhibition of BK current and cerebral artery constriction is mediated by the β1 transmembrane domain 2.Role of protein kinase Calpha in regulation of [Ca2+](I) and force in human myometrium.The large-conductance voltage- and Ca2+ -activated K+ channel and its γ1 subunit modulate mouse uterine artery function during pregnancy.Micronucleus formation during chromatin condensation and under apoptotic conditions.NFATc3 regulates Kv2.1 expression in arterial smooth muscle.The voltage-dependent L-type Ca2+ (CaV1.2) channel C-terminus fragment is a bi-modal vasodilator.
P2860
Q28359458-B7512D5E-D3BD-42C5-9D29-647E5648E893Q28365703-8724357A-EA03-4CAC-BEBB-F776FE2C0573Q28568988-473F4801-233E-49C7-8A45-C8BC0DB41522Q28570184-591D6D2B-8B76-4C44-858A-EAAB70660E03Q28579467-0BB4F095-40AE-4186-AE5E-00FC47B30F26Q30454295-DDA16F85-9A58-415C-923A-4EB01CA1D5DDQ30501923-253E260A-9EF0-4C16-B386-2F95A374CCCDQ33498339-BD7EE8C3-716E-4F10-BF1F-41EFB744E6B9Q34868795-A032B547-5764-4CAA-B1C5-3A7C9D033FDAQ35543518-64A4580C-71F6-4C1A-9486-7BB3B599741AQ35873815-7630A00B-134F-48CA-A01D-31F027414572Q36530946-7D725AB1-5245-4954-89A4-5812D5A38ABBQ36726571-82290787-26ED-40D6-AE4B-0E31D775AC1EQ38229512-FE1DFCD8-5BE6-4F4E-B358-74B2FA60E440Q38323738-A62B5311-6D11-4D35-96C6-89E66183B70DQ38331934-25693450-D95C-48E0-90CD-5829DA355B9FQ39716985-0C07B635-14D2-445E-AFE9-B811E519E921Q40172293-EB6A9904-91C8-4C07-861E-CF7E6B56EB61Q41148336-759E0C75-A873-47F2-83FA-538CF7716E13Q42466567-241F80DC-5768-4CF3-A95B-EF3600BA060BQ42671755-617E17E6-A1F8-4704-955E-F03F134A6BBEQ42868138-881782C4-ADEE-49FE-88AF-649AE19311EBQ44598316-1A429E21-25DF-47F6-A06B-E76D22354F60Q44669984-9C5F8225-F7B7-4E37-B19E-697C89174291Q45882462-32D2509E-0313-4971-AE0F-C278E6C585D2Q46302314-C996A1D2-5270-464D-8FD5-1915F5A812F7Q46353008-7C0F3394-1A6F-4B6C-88BE-CDE564FA2C76Q48272290-56A22E57-36CA-4E7A-8102-2FC10F92E1C8Q48275133-D8862A97-2AF8-429E-A5CC-5D2AB05DEAF0Q50795101-D134EE03-72F4-4613-8AA3-5A1078C5D0FCQ53112347-50D8701C-4EF7-428A-9A8A-7EF2867940DF
P2860
Reversible permeabilization. A novel technique for the intracellular introduction of antisense oligodeoxynucleotides into intact smooth muscle.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Reversible permeabilization. A ...... des into intact smooth muscle.
@ast
Reversible permeabilization. A ...... des into intact smooth muscle.
@en
type
label
Reversible permeabilization. A ...... des into intact smooth muscle.
@ast
Reversible permeabilization. A ...... des into intact smooth muscle.
@en
prefLabel
Reversible permeabilization. A ...... des into intact smooth muscle.
@ast
Reversible permeabilization. A ...... des into intact smooth muscle.
@en
P2093
P356
P1433
P1476
Reversible permeabilization. A ...... des into intact smooth muscle.
@en
P2093
P304
P356
10.1161/01.RES.77.2.220
P577
1995-08-01T00:00:00Z